Brief: Galera Therapeutics - Expects To Report Co Had Cash And Cash Equivalents & Short-Term Investments Of About $31.6 Million As Of December 31, 2022
15/02/2023 14:15
Feb 15 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA THERAPEUTICS - EXPECTS TO REPORT CO HAD CASH AND
CASH
EQUIVALENTS & SHORT-TERM INVESTMENTS OF ABOUT $31.6 MILLION AS
OF DECEMBER 31, 2022
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement